Found: 12
Select item for more details and to access through your institution.
nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 1, p. 14, doi. 10.1159/000357938
- By:
- Publication type:
- Article
Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan.
- Published in:
- Internal Medicine, 2022, v. 61, n. 3, p. 379, doi. 10.2169/internalmedicine.7124-21
- By:
- Publication type:
- Article
Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease.
- Published in:
- Internal Medicine, 2021, v. 60, n. 17, p. 2831, doi. 10.2169/internalmedicine.6470-20
- By:
- Publication type:
- Article
Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression.
- Published in:
- Oncology Letters, 2021, v. 22, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12900
- By:
- Publication type:
- Article
Respiratory disease in workers handling cross-linked water-soluble acrylic acid polymer.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0284837
- By:
- Publication type:
- Article
Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 17, p. 1390, doi. 10.1111/1759-7714.15324
- By:
- Publication type:
- Article
Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 3, p. 249, doi. 10.1080/0284186X.2019.1695062
- By:
- Publication type:
- Article
A Case of Colorectal Cancer with Double-activating Epidermal Growth Factor Receptor Mutations.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 9, p. 1138, doi. 10.1093/jjco/hyr113
- By:
- Publication type:
- Article
A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 6, p. 956, doi. 10.1093/jjco/hyab048
- By:
- Publication type:
- Article
Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1447, doi. 10.1093/jjco/hyaa152
- By:
- Publication type:
- Article
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers.
- Published in:
- Cancer Science, 2021, v. 112, n. 5, p. 1853, doi. 10.1111/cas.14801
- By:
- Publication type:
- Article
Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter.
- Published in:
- Cancer Science, 2008, v. 99, n. 9, p. 1747, doi. 10.1111/j.1349-7006.2008.00875.x
- By:
- Publication type:
- Article